Fresh Recalls

FDAClass II · Drug · Recall D-0673-2026 · Recalled July 15, 2026

Bortezomib for Injection 3 recall — Reliance Life Sciences Private Limited

Agency report date: July 15, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Bortezomib for Injection 3
Company / brand
Reliance Life Sciences Private
Lot / serial / date codes
Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
Distribution
Nationwide in the USA
Agency product description and boundaries

Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Lack of Sterility Assurance

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Bortezomib for Injection 3

3. Open the official notice or contact

Official recall ID
D-0673-2026
Brand
Reliance Life Sciences Private
Classification
Class II
Units affected
11,400 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Navi Mumbai, N/A, India
Firm address
Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
99312
Recall initiated
June 24, 2026
FDA classified
July 8, 2026
FDA report date
July 15, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page